Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
American International
AIG
$41.9B
| $88.4M | 0.17% |
+1,636,160
| New | +$88.4M |
|
102
Usana Health Sciences
USNA
$394M
| $88.3M | 0.17% |
1,454,400
-93,966
| -6% | -$5.53M |
|
103
ICU Medical
ICUI
$3.93B
| $87.7M | 0.17% |
842,000
+29,200
| +4% | +$2.79M |
|
104
Euronet Worldwide
EEFT
$3.02B
| $86M | 0.16% |
1,159,945
-34,600
| -3% | -$2.44M |
|
105
America Movil
AMX
$78.1B
| $85.9M | 0.16% |
5,533,200
+1,518,100
| +38% | +$21M |
|
106
Pinnacle West Capital
PNW
$12.9B
| $85.5M | 0.16% |
1,138,300
+176,600
| +18% | +$12.1M |
|
107
BCE
BCE
$19.9B
| $84.8M | 0.16% |
1,860,671
-137,600
| -7% | -$5.75M |
|
108
Coca-Cola Europacific Partners
CCEP
$46.5B
| $83.8M | 0.16% |
1,651,392
+244,100
| +17% | +$11.8M |
|
109
Digital Realty Trust
DLR
$73.7B
| $82.5M | 0.16% |
932,000
+155,700
| +20% | +$12.6M |
|
110
Capitol Federal Financial
CFFN
$1.08B
| $82.4M | 0.16% |
6,210,897
+295,900
| +5% | +$3.69M |
|
111
Old Republic International
ORI
$10.3B
| $81.6M | 0.16% |
4,464,285
+3,540,900
| +383% | +$63.8M |
|
112
Humana
HUM
$46.7B
| $81.6M | 0.16% |
446,000
+317,200
| +246% | +$55M |
|
113
Ultrapar
UGP
$6.87B
| $81M | 0.15% |
8,402,000
-309,200
| -4% | -$2.45M |
|
114
United Airlines
UAL
$38.4B
| $80.6M | 0.15% |
1,346,100
-78,300
| -5% | -$4.16M |
|
|
MZTI
115
The Marzetti Company
MZTI
$2.94B
| $80.6M | 0.15% |
728,600
-4,000
| -0.5% | -$429K |
|
116
Chunghwa Telecom
CHT
$33.2B
| $80.3M | 0.15% |
2,379,948
+197,864
| +9% | +$6.25M |
|
117
DaVita
DVA
$15.1B
| $80.1M | 0.15% |
1,091,500
+167,400
| +18% | +$11.3M |
|
118
Cinemark Holdings
CNK
$3.82B
| $79.3M | 0.15% |
2,213,400
-468,700
| -17% | -$14.9M |
|
119
British American Tobacco
BTI
$132B
| $79.3M | 0.15% |
1,356,400
+139,000
| +11% | +$7.65M |
|
120
Mid-America Apartment Communities
MAA
$15.6B
| $79.2M | 0.15% |
775,000
+125,638
| +19% | +$11.7M |
|
121
Philip Morris
PM
$301B
| $78.9M | 0.15% |
804,500
+406,700
| +102% | +$37.3M |
|
122
Regeneron Pharmaceuticals
REGN
$68.8B
| $78.2M | 0.15% |
216,962
+109,700
| +102% | +$45.2M |
|
123
Molina Healthcare
MOH
$10.3B
| $77.9M | 0.15% |
1,208,150
+159,572
| +15% | +$9.48M |
|
124
Northrop Grumman
NOC
$77B
| $77.7M | 0.15% |
+392,500
| New | +$74.1M |
|
125
Pan American Silver
PAAS
$18.6B
| $77.6M | 0.15% |
7,139,712
+1,922,912
| +37% | +$16.5M |
|
Similar funds
Renaissance Technologies's Q1 2016 Portfolio in Review
As of Q1 2016, Renaissance Technologies held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Renaissance Technologies's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Renaissance Technologies added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Renaissance Technologies's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Renaissance Technologies fully exited Apple in Q1 2016, selling an estimated $470M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Renaissance Technologies opened 498 new positions and closed 403 in Q1 2016.
- Renaissance Technologies's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.